Key statistics
As of last trade Edwards Lifesciences Corp (EWL:DUS) traded at 72.27, -3.37% below its 52-week high of 74.79, set on Nov 26, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 72.33 |
|---|---|
| High | 72.33 |
| Low | 72.27 |
| Bid | 72.51 |
| Offer | 73.25 |
| Previous close | 73.21 |
| Average volume | 7.43 |
|---|---|
| Shares outstanding | 580.80m |
| Free float | 572.50m |
| P/E (TTM) | 47.86 |
| Market cap | 50.22bn USD |
| EPS (TTM) | 1.81 USD |
Data delayed at least 15 minutes, as of Mar 02 2026 08:10 GMT.
More ▼
Press releases
- Edwards Lifesciences Advances Structural Heart Care Through Innovation and Purpose
- Edwards Lifesciences to Present at the Barclays and Leerink Partners Global Healthcare Conferences
- Edwards Lifesciences to Present at Citi’s 2026 Unplugged Medtech and Life Sciences Access Day
- Edwards Lifesciences Reports Fourth Quarter Results
- Edwards Lifesciences to Host Earnings Conference Call on February 10, 2026
- Edwards Lifesciences to Present at the TD Cowen 46th Annual Health Care Conference
- Edwards Comments on JenaValve Acquisition
- FDA Approves Edwards Lifesciences' SAPIEN M3 Mitral Valve Replacement System as First Transseptal Transcatheter Therapy
- Edwards Lifesciences to Present at the 44th Annual J.P. Morgan Healthcare Conference
- Edwards Lifesciences Reaffirms Strategy for Sustainable, Differentiated Growth at Annual Investor Conference
More ▼
